Home
Disease
Treatment
Genomics
issues
Resources
Culture
Meetngs
Images
Links
Training

"Vivax Malaria Research: 2009 and Beyond" (Panama Canal, Panama, 24-28 May 2009)

The third Plasmodium vivax research conference was held in Panama, May 24-28, 2009. The purpose of the conference was to assess our current knowledge of vivax malaria and prioritize the critical needs for development of effective prophylactic and curative therapies. Similar to the two previous conferences, the meeting produced a report that summarizes the consensus of the conference discussions and conclusions, and that will guide allocation of resources for research and control measures.

"Vivax Malaria Research: 2005 and Beyond" (Rockville, MD, USA, 9-10 December 2005)

The second vivax malaria conference was convened at The Institute for Genomic Research (TIGR) to mark the completion of the P. vivax genome sequence; to continue the momentum generated from the first vivax malaria research conference held in 2002; to bring together P. vivax researchers from a multitude of disciplines and from developed and endemic countries to discuss future priorities; and to provide hands-on experience of bioinformatics techniques that can be used to manipulate the P. vivax genome sequence data. One product of the conference was an updated list of recommendations for enhancing P. vivax research, resources, and training.

"Vivax Malaria Research: 2002 and Beyond" (Bangkok, Thailand, 3-8 February 2002)

Responding to a pervasive sense in the malaria research community that P. vivax research had been neglected compared to P. falciparum efforts, the first conference devoted entirely to the topic was convened in 2002. Trends in Parasitology subsequently published 'A Focus on Plasmodium vivax Research', a collection of TiPs articles on topics presented at the meeting. These articles can be downloaded as PDF files using the links below. Several recommendations to specifically enhance P. vivax research were also drafted.

Focus on Plasmodium vivax
Barbara Sina
The assessment of antimalarial drug efficacy
Nicolas J. White
Can primaquine therapy for vivax malaria be improved?
J. Kevin Baird and Karl H. Rieckmann
The paroxysm of Plasmodium vivax malaria
Nadira D. Karunaweera, Subadra K. Wijesekera, Deepani Wanasekera, Kamini N. Mendis, and Richard Carter
The Plasmodium vivax genome sequencing project
Jane Carlton
The genetic diversity of Plasmodium vivax populations
Liwang Cui, Ananias A. Escalante, Mallika Imwong and Georges Snounou
Speculations on the origins of Plasmodium vivax malaria
Richard Carter
Plasmodium vivax under the microscope: the Aotus model
V. Ann Stewart
Plasmodium vivax transmission: chances for control?
Jetsuman Sattabongkot, Takafumi Tsuboi, Gabriela E. Zollner, Jeeraphat Sirichaisinthop, and Liwang Cui
The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand
Georges Snounou and Nicholas J. White
Why do we need to know more about mixed Plasmodium species infections in humans?
Peter A. Zimmerman, Rajeev K. Mehlotra, Laurin J. Kasehagen, and James W. Kazura
All articles are reprinted from Trends in Parasitology, Copyright 2002, 2003, 2004, with permission from Elsevier